Status:
COMPLETED
Scenario Tailored Opioid Messaging Program (STOMP) to Improve Risk Understanding in Young Adults
Lead Sponsor:
University of Michigan
Collaborating Sponsors:
National Institute on Drug Abuse (NIDA)
Conditions:
Pain, Postoperative
Medication Adherence
Eligibility:
All Genders
15-24 years
Phase:
NA
Brief Summary
Legitimate prescription opioid use during adolescence has been associated with later prescription opioid misuse and substance use disorder symptoms during adulthood. Thus, primary prevention intervent...
Detailed Description
The goal of this research is to improve opioid analgesic safety and efficacy by optimizing opioid risk recognition, informed decision-making including misuse among 15-24 year olds who are prescribed t...
Eligibility Criteria
Inclusion
- Undergoing an elective surgical procedure for which it is expected they will receive a prescription pain medicine for management of pain during recovery at home.
Exclusion
- Undergoing non-elective procedure
- Cognitive impairment precluding self-reporting of pain
- Hematologic/oncologic condition
- Liver of kidney conditions precluding usual analgesic prescription patters (opioid plus a non-opioid)
- Use of opioids for prolonged pain pre-operatively (\<2 weeks)
Key Trial Info
Start Date :
November 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2021
Estimated Enrollment :
503 Patients enrolled
Trial Details
Trial ID
NCT03863353
Start Date
November 1 2019
End Date
December 1 2021
Last Update
April 6 2022
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Michigan, C.S. Mott Children's Hospital
Ann Arbor, Michigan, United States, 48109
2
University of Michigan
Ann Arbor, Michigan, United States, 48109